RNA toxic gain-of-function model for DM1 pathogenesis. Mutant DMPK RNA... | Download Scientific Diagram
Entrada Therapeutics | Myotonic Dystrophy Type 1 (DM1)
IJMS | Free Full-Text | Disrupting the Molecular Pathway in Myotonic Dystrophy
Ligand for Potential Treatment of Myotonic Dystrophy Type 1 (DM1) | UIUC Office of Technology Management
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene: Molecular Therapy - Nucleic Acids
Gene Therapy and Gene Editing for Myotonic Dystrophy | SpringerLink
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2 - ScienceDirect
Epigenetics and Myotonic Dystrophy Type 1 | Encyclopedia MDPI
Novel mouse model of myotonic dystrophy displays reversible cardiac disease features of the condition
Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids
Steinert's myotonic dystrophy - Symptoms, diagnosis and treatment
Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1: Molecular Therapy
IJMS | Free Full-Text | Epigenetics of Myotonic Dystrophies: A Minireview
New myotonic dystrophy type 1 mouse model | Cell Research
DM1 pathogenetic mechanisms and therapeutic strategies. The actions of... | Download Scientific Diagram
Model for the molecular consequences of triplet expansion in DM1. In... | Download Scientific Diagram
IJMS | Free Full-Text | Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
RNA toxicity model for DM1 pathogenesis and potential therapeutic... | Download Scientific Diagram
Strategies for DM1 gene therapy. A) Degradation of mutant RNA by... | Download Scientific Diagram
Cardiovascular manifestations of Myotonic Dystrophy
Myotonic dystrophy - Wikipedia
Entrada Therapeutics | Myotonic Dystrophy Type 1 (DM1)
Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2 | European Journal of Human Genetics
Frontiers | Muscle wasting in myotonic dystrophies: a model of premature aging
Myopathies without EOM Weakness: Facioscapulohumeral + Myotonic Dystrophy
Figure 1 from Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms | Semantic Scholar
